Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | BrJP (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199 |
Resumo: | ABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours. |
id |
SBED-2_c78da61e52dd41774c020fa23d1d24ff |
---|---|
oai_identifier_str |
oai:scielo:S2595-31922020000300199 |
network_acronym_str |
SBED-2 |
network_name_str |
BrJP (Online) |
repository_id_str |
|
spelling |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia modelAnalgesiaFibroblastsKeratinocytesPeripheral nervous systemSkinABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours.Sociedade Brasileira para o Estudo da Dor2020-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199BrJP v.3 n.3 2020reponame:BrJP (Online)instname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/2595-0118.20200038info:eu-repo/semantics/openAccessSouza,Cíntia ÁvilaSantos,Gilson Gonçalves dosFarias,Felipe HertzingSouza Júnior,Eli ÁvilaParada,Carlos Amilcareng2020-09-18T00:00:00Zoai:scielo:S2595-31922020000300199Revistahttps://sbed.org.br/publicacoes-publicacoes-bjp/ONGhttps://old.scielo.br/oai/scielo-oai.phpdkt@terra.com.br || dor@dor.org.br2595-31922595-0118opendoar:2020-09-18T00:00BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)false |
dc.title.none.fl_str_mv |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
title |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
spellingShingle |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model Souza,Cíntia Ávila Analgesia Fibroblasts Keratinocytes Peripheral nervous system Skin |
title_short |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
title_full |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
title_fullStr |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
title_full_unstemmed |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
title_sort |
Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model |
author |
Souza,Cíntia Ávila |
author_facet |
Souza,Cíntia Ávila Santos,Gilson Gonçalves dos Farias,Felipe Hertzing Souza Júnior,Eli Ávila Parada,Carlos Amilcar |
author_role |
author |
author2 |
Santos,Gilson Gonçalves dos Farias,Felipe Hertzing Souza Júnior,Eli Ávila Parada,Carlos Amilcar |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Souza,Cíntia Ávila Santos,Gilson Gonçalves dos Farias,Felipe Hertzing Souza Júnior,Eli Ávila Parada,Carlos Amilcar |
dc.subject.por.fl_str_mv |
Analgesia Fibroblasts Keratinocytes Peripheral nervous system Skin |
topic |
Analgesia Fibroblasts Keratinocytes Peripheral nervous system Skin |
description |
ABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/2595-0118.20200038 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
publisher.none.fl_str_mv |
Sociedade Brasileira para o Estudo da Dor |
dc.source.none.fl_str_mv |
BrJP v.3 n.3 2020 reponame:BrJP (Online) instname:Sociedade Brasileira para o Estudo da Dor (SBED) instacron:SBED |
instname_str |
Sociedade Brasileira para o Estudo da Dor (SBED) |
instacron_str |
SBED |
institution |
SBED |
reponame_str |
BrJP (Online) |
collection |
BrJP (Online) |
repository.name.fl_str_mv |
BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED) |
repository.mail.fl_str_mv |
dkt@terra.com.br || dor@dor.org.br |
_version_ |
1754732510321836032 |